The Milken Institute Center for Strategic Philanthropy, in partnership with the Ann Theodore Foundation (ATF), is pleased to announce a new Request for Proposals (RFP) focused on understanding the underlying biology of sarcoidosis, an immune dysregulation condition. The Ann Theodore Foundation Breakthrough Sarcoidosis Initiative is one of the largest investments in sarcoidosis basic science and has the potential to accelerate the speed at which new discoveries and therapies are made.
The second cycle of the Breakthrough Sarcoidosis Initiative funding cycle is open for applications now through Tuesday, January 10, 2023. Teams can apply for funding up to $575,000 over a two-year period. An informational session about the program and the initiative will take place on Wednesday, September 28, at 3:00 p.m. EDT. Register for Zoom event here.
Sarcoidosis is hallmarked by clusters of immune cells, known as granulomas, forming in various organs throughout the body. It is often observed in the lungs, but virtually any organ can be impacted. Furthermore, it can be a chronic and devastating condition. Symptoms can include difficulty breathing, fatigue, and arrhythmia, and can lead to severe organ damage and death. While anyone can be impacted, it impacts African-American women at higher rates than other demographics.
“It’s inspiring to see the ways in which strategic philanthropists are stepping up and providing the capital needed to advance understanding of a disease like sarcoidosis,” said Melissa Stevens, executive vice president of philanthropy at the Milken Institute.
This funding program builds on a major Giving Smarter Guide that laid out the critical need to better understand this devastating disease and several promising opportunities for philanthropy to step in. More than $3 million in sarcoidosis-focused research funding was recently awarded to six US-based teams.
Scientific Advisory Board member Bob Baughman, president emeritus of the World Association of Sarcoidosis and other Granulomatous Disorders, added, “We believe this infusion of funds will pave the way toward solutions for those affected by this debilitating disease.”
Awardees for this cycle of funding are expected to be notified in spring 2023.
Mala Persaud
[email protected]
The Ann Theodore Foundation Breakthrough Sarcoidosis Initiative (ATF-BSI) was designed to increase our understanding of sarcoidosis biology, providing a foundation for future improvements in clinical care for individuals living with the condition. ATF-BSI was launched in 2021 and seeks to grow the sarcoidosis research workforce by providing additional support for researchers.
The Milken Institute Center for Strategic Philanthropy advises individuals and foundations seeking to develop and implement transformational giving strategies and offers leadership to make the philanthropic landscape more effective. We conduct deep due diligence across a range of issue areas and identify the areas where philanthropic capital can make the biggest impact and create a better world.
The Milken Institute is a nonprofit, nonpartisan think tank focused on accelerating measurable progress on the path to a meaningful life. With a focus on financial, physical, mental, and environmental health, we bring together the best ideas and innovative resourcing to develop blueprints for tackling some of our most critical global issues through the lens of what’s pressing now and what’s coming next.
